Pre-earnings options volume in DexCom (DXCM) is 2.6x normal with puts leading calls 9:5. Implied volatility suggests the market is anticipating a move near 8.6%, or $6.12, after results are released. Median move over the past eight quarters is 5.6%.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DXCM:
- Is DXCM a Buy, Before Earnings?
- ISRG, LLY, or DXCM: Which “Strong Buy” Healthcare Stock Has the Highest Upside Potential?
- DexCom price target lowered to $100 from $115 at RBC Capital
- DexCom price target lowered to $107 from $120 at BTIG
- Dexcom’s G7 Sensor Approval Boosts Buy Rating Amid Strategic Advancements